HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ayse Ulusoy Selected Research

Synucleinopathies

11/2021Synapsin Condensates Recruit alpha-Synuclein.
7/2018In vivo models of alpha-synuclein transmission and propagation.
1/2018Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson's disease.
1/2018Long-lasting pathological consequences of overexpression-induced α-synuclein spreading in the rat brain.
1/2018LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation.
1/2017Brain-to-stomach transfer of α-synuclein via vagal preganglionic projections.
3/2016Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice.
3/2015Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury.
4/2013α-Synuclein elevation in human neurodegenerative diseases: experimental, pathogenetic, and therapeutic implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ayse Ulusoy Research Topics

Disease

17Parkinson Disease (Parkinson's Disease)
01/2022 - 08/2008
9Synucleinopathies
11/2021 - 04/2013
5Neurodegenerative Diseases (Neurodegenerative Disease)
07/2018 - 08/2008
4Disease Progression
07/2018 - 01/2011
1Iron Overload
01/2021
1Cognitive Dysfunction
01/2020
1Pathologic Processes
07/2018
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Inflammation (Inflammations)
07/2012
1Neuroinflammatory Diseases
07/2012
1Drug-Induced Dyskinesia (Dyskinesia, Drug Induced)
07/2010
1Dyskinesias (Dyskinesia)
07/2010

Drug/Important Bio-Agent (IBA)

14SynucleinsIBA
11/2021 - 01/2010
5Proteins (Proteins, Gene)FDA Link
11/2021 - 02/2012
3alpha-SynucleinIBA
01/2022 - 08/2010
3Dopamine (Intropin)FDA LinkGeneric
09/2012 - 08/2008
2Neuroprotective AgentsIBA
01/2021 - 08/2011
1LipidsIBA
11/2021
1Transferrin Receptors (Transferrin Receptor)IBA
01/2021
1IronIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2018
1Oxidants (Oxidizing Agents)IBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA
02/2012
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
08/2011
1NeurotoxinsIBA
08/2011
1Therapeutic UsesIBA
08/2011
1Nerve Growth Factors (Neurotrophins)IBA
01/2011
1PolymersIBA
08/2010
1ApomorphineFDA Link
07/2010
1Levodopa (L Dopa)FDA LinkGeneric
07/2010

Therapy/Procedure

1Precision Medicine
01/2022
1Therapeutics
01/2011